Your browser doesn't support javascript.
loading
High serum free IL-18 is associated with decreased omalizumab efficacy: findings from a 2-year omalizumab treatment study.
Morimoto, Chie; Matsumoto, Hisako; Tajiri, Tomoko; Gon, Yasuhiro; Ito, Reiko; Hashimoto, Shu; Suzukawa, Maho; Ohta, Ken; Izuhara, Kenji; Ono, Junya; Ohta, Shoichiro; Ito, Isao; Oguma, Tsuyoshi; Kanemitsu, Yoshihiro; Nagasaki, Tadao; Izuhara, Yumi; Niimi, Akio; Hirai, Toyohiro.
Afiliação
  • Morimoto C; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Matsumoto H; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Tajiri T; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Gon Y; Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University School of Medical Sciences, Nagoya, Japan.
  • Ito R; Division of Respiratory Medicine, Department of Internal Medicine, Nihon University, Tokyo, Japan.
  • Hashimoto S; Division of Respiratory Medicine, Department of Internal Medicine, Nihon University, Tokyo, Japan.
  • Suzukawa M; Division of Respiratory Medicine, Department of Internal Medicine, Nihon University, Tokyo, Japan.
  • Ohta K; Respiratory Center, National Hospital Organization Tokyo National Hospital, Tokyo, Japan.
  • Izuhara K; Respiratory Center, National Hospital Organization Tokyo National Hospital, Tokyo, Japan.
  • Ono J; Division of Medical Biochemistry, Department of Biomolecular Sciences, Saga Medical School, Saga, Japan.
  • Ohta S; Shino-Test Corporation, Sagamihara, Japan.
  • Ito I; Department of Laboratory Medicine, Saga Medical School, Saga, Japan.
  • Oguma T; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Kanemitsu Y; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Nagasaki T; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Izuhara Y; Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University School of Medical Sciences, Nagoya, Japan.
  • Niimi A; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Hirai T; Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
J Asthma ; 58(9): 1133-1142, 2021 09.
Article em En | MEDLINE | ID: mdl-32375555
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Antiasmáticos / Interleucina-18 / Omalizumab Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: J Asthma Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Antiasmáticos / Interleucina-18 / Omalizumab Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: J Asthma Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão